#Veterinary Pain Management Market size

[mitalipingale]

https://justpaste.it/g1dwv

The Veterinary Pain Management Market in 2023 is US$ 1.92 billion, and is expected to reach US$ 3.29 billion by 2031 at a CAGR of 6.9%.

[mordormr]

The Compounding Pharmacy Market: Trends, Challenges, and Future Outlook

The Compounding Pharmacy Market Size is projected to be valued at USD 14.31 billion in 2024 and is expected to grow to USD 18.86 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.68% during the forecast period from 2024 to 2029.

Market Overview and Growth Drivers

The global compounding pharmacy market has experienced significant growth in recent years, fueled by several key factors:

Rising Demand for Customized Medications: The growing awareness of personalized medicine has led to an increased demand for compounded medications that cater to individual patient needs. This includes unique dosages, delivery methods, and formulations that may not be available in commercial products.

Increasing Prevalence of Chronic Diseases: With the rise in chronic diseases such as diabetes, cancer, and cardiovascular disorders, there is a heightened need for tailored treatments that compounding pharmacies can provide.

Ageing Population: The global aging population is driving demand for specialized medications, as older adults often require unique formulations to manage their health conditions effectively.

2. Types of Compounding Pharmacies

Compounding pharmacies can be classified into several categories based on their specific services:

Sterile Compounding Pharmacies: These pharmacies specialize in preparing sterile medications, such as injections and infusions, often required in hospital settings or for patients with complex medical needs.

Non-Sterile Compounding Pharmacies: These pharmacies create non-sterile medications, such as topical creams, capsules, and liquid formulations, catering to patients with various health conditions.

Specialty Compounding Pharmacies: These pharmacies focus on niche areas, such as hormone replacement therapy, veterinary compounding, or specific therapeutic areas like pain management.

3. Key Market Trends

Several trends are shaping the compounding pharmacy industry:

Technological Advancements: The integration of technology in compounding processes is enhancing efficiency and accuracy. Automated compounding systems and software solutions are helping pharmacies improve productivity and reduce human error.

Increased Regulatory Scrutiny: The compounding pharmacy industry is experiencing heightened regulatory oversight to ensure patient safety and product quality. Compliance with regulations from agencies such as the U.S. Food and Drug Administration (FDA) is becoming increasingly important.

Telehealth Integration: The rise of telehealth services has influenced the compounding pharmacy market, as healthcare providers can now prescribe compounded medications more conveniently, leading to increased demand for personalized treatments.

Focus on Quality and Safety: Patients and healthcare providers are placing greater emphasis on the quality and safety of compounded medications, driving pharmacies to adopt stringent quality assurance measures and adhere to best practices.

4. Challenges Facing the Compounding Pharmacy Market

While the compounding pharmacy industry is growing, it faces several challenges:

Regulatory Compliance: Navigating the complex regulatory landscape can be challenging for compounding pharmacies. Adherence to state and federal regulations requires significant resources and expertise.

Market Competition: The compounding pharmacy market is competitive, with numerous players vying for market share. Compounding pharmacies must differentiate themselves through quality, service, and innovative solutions.

Limited Insurance Coverage: Many compounded medications are not covered by insurance, which can limit patient access and impact the profitability of compounding pharmacies.

5. Competitive Landscape

The compounding pharmacy market is characterized by a mix of established players and emerging companies. Key players include:

Wedgewood Pharmacy: A leading compounding pharmacy known for its high-quality compounded medications and commitment to patient safety.

PioneerRx: A pharmacy management software provider that supports compounding pharmacies with technology solutions to enhance efficiency and accuracy.

The Compounding Center: Specializing in customized medications, this pharmacy is recognized for its focus on patient-centered care and innovative formulations.

Conclusion

The compounding pharmacy market is an essential and growing segment of the healthcare industry, driven by the demand for personalized medications and the increasing prevalence of chronic diseases. While challenges such as regulatory compliance and market competition exist, the future looks bright as compounding pharmacies continue to innovate and adapt to meet the needs of patients and healthcare providers. By prioritizing quality, safety, and patient-centered care, the compounding pharmacy industry can continue to thrive and make a meaningful impact on patient health.

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence https://www.mordorintelligence.com/industry-reports/compounding-pharmacy-market  

[priyanshisingh]

Pet Food and Supplement Market Report: Opportunities and Challenges (2023-2032)

The Pet Food and Supplement Market is projected to grow from USD 119,095 million in 2024 to USD 185,563.87 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.70%.

The pet food and supplement market has experienced significant growth in recent years, driven by the increasing humanization of pets, where pet owners treat their animals as integral members of the family. This trend has led to a rising demand for high-quality, nutritious, and tailored pet food products that mirror the health and wellness trends seen in human food. Pet owners are now more informed and concerned about the ingredients in their pets' diets, seeking out foods that are not only palatable but also beneficial for their pets' overall health. As a result, the market has seen a surge in the availability of premium pet foods, including grain-free, organic, and natural formulations, as well as diets specifically designed to address health issues such as obesity, allergies, and digestive problems.

The growth of the pet food market is also closely linked to the increasing awareness of the specific nutritional needs of different pets based on factors such as age, breed, and activity level. For example, senior pets may require diets with joint-supporting supplements like glucosamine, while active or working dogs might benefit from higher protein content. This has led to the development of life-stage-specific and breed-specific formulas, catering to the unique requirements of pets at various stages of their lives. Moreover, the rise of personalized pet nutrition, where diets are tailored to the individual needs of a pet based on veterinary recommendations or genetic testing, is becoming a popular trend among pet owners who are willing to invest in customized solutions to ensure their pets' well-being.

In addition to pet food, the supplement market for pets is expanding rapidly, reflecting the growing interest in preventive health care and wellness for animals. Pet supplements, which include vitamins, minerals, probiotics, omega-3 fatty acids, and joint health products, are increasingly being used to support specific health concerns, such as joint mobility, coat health, digestive health, and immune system function. The popularity of supplements is driven by a combination of factors, including the aging pet population, the desire to manage chronic conditions naturally, and the influence of human health trends on pet care practices. For instance, the use of CBD supplements for pets has gained traction, particularly for managing anxiety, pain, and inflammation, mirroring the rise of CBD products in the human wellness market.

The pet food and supplement market is diverse, with a wide range of products designed to meet the specific needs of different pets. Here’s an overview of the main types of pet food and supplements:

Pet Food Types

Dry Food (Kibble):

Description: Dry food is one of the most common types of pet food, particularly for dogs and cats. It is shelf-stable, easy to store, and convenient to serve. Kibble is typically made by blending various ingredients into a dough, which is then baked or extruded into small, bite-sized pieces.

Benefits: Helps maintain dental health by reducing plaque and tartar buildup. It is also cost-effective and has a long shelf life.

Wet Food (Canned Food):

Description: Wet food is available in cans, pouches, or trays and has a higher moisture content than dry food. It is often more palatable to pets due to its softer texture and stronger aroma.

Benefits: Good for pets who need extra hydration, such as those with urinary tract issues. It is also easier to eat for pets with dental problems.

Semi-Moist Food:

Description: Semi-moist food falls between dry and wet food in terms of moisture content. It is usually packaged in pouches and has a soft, chewy texture.

Benefits: Convenient and easy to serve, often more appealing to picky eaters due to its texture and flavor.

Raw Food:

Description: Raw food diets, often referred to as BARF (Biologically Appropriate Raw Food) diets, consist of uncooked meat, bones, fruits, and vegetables. This diet aims to mimic the natural diet of wild animals.

Benefits: Proponents believe raw food diets offer better digestion, healthier skin and coat, and more energy. However, it requires careful preparation and handling to avoid contamination.

Freeze-Dried and Dehydrated Food:

Description: Freeze-dried and dehydrated foods are raw or cooked foods that have had the moisture removed to preserve them. They are often rehydrated with water before feeding.

Benefits: Offers the benefits of raw food with the convenience of dry food. It is lightweight, easy to store, and has a long shelf life.

Grain-Free Food:

Description: Grain-free food is formulated without common grains like wheat, corn, or rice, often using alternative carbohydrate sources such as potatoes or peas.

Benefits: Ideal for pets with grain allergies or sensitivities. It is believed by some to be closer to a pet's natural diet, although this is a topic of debate among veterinarians.

Prescription Diets:

Description: Prescription diets are specialized pet foods formulated to address specific health conditions, such as kidney disease, obesity, or gastrointestinal issues. These are usually recommended by veterinarians.

Benefits: Tailored nutrition that can help manage or improve certain health conditions in pets.

Organic and Natural Food:

Description: Organic pet food is made from ingredients that are grown without synthetic pesticides, fertilizers, or genetically modified organisms (GMOs). Natural food typically contains no artificial additives or preservatives.

Benefits: Perceived as healthier and safer, particularly for pets with sensitivities or owners who are concerned about artificial ingredients.

Homemade Pet Food:

Description: Homemade pet food is prepared by pet owners using fresh ingredients, often based on recipes formulated by veterinarians or pet nutritionists.

Benefits: Allows for complete control over ingredients, making it easier to tailor diets to specific health needs or preferences.

Pet Supplement Types

Vitamins and Minerals:

Description: Supplements that provide essential vitamins and minerals, such as vitamin A, B-complex vitamins, vitamin E, calcium, and zinc. These are often used to correct deficiencies or support overall health.

Benefits: Supports various bodily functions, including immune health, bone strength, and skin and coat health.

Joint Supplements:

Description: Common joint supplements include glucosamine, chondroitin, MSM (methylsulfonylmethane), and omega-3 fatty acids. These supplements are often used for pets with arthritis or joint pain.

Benefits: Helps maintain joint mobility, reduces inflammation, and supports cartilage health, particularly in aging or active pets.

Probiotics:

Description: Probiotics contain live beneficial bacteria that support gut health. They are available in powder, capsule, or chewable forms.

Benefits: Promotes a healthy digestive system, improves nutrient absorption, and helps manage gastrointestinal issues such as diarrhea or constipation.

Omega-3 and Fatty Acid Supplements:

Description: Omega-3 supplements, often derived from fish oil or flaxseed oil, provide essential fatty acids that are not typically produced by the pet’s body.

Benefits: Supports skin and coat health, reduces inflammation, and can help with heart health and cognitive function.

CBD and Calming Supplements:

Description: CBD supplements are derived from hemp and are used for their potential calming and anti-inflammatory effects. Other calming supplements may contain ingredients like L-theanine, chamomile, or valerian root.

Benefits: Helps manage anxiety, stress, and pain in pets, particularly in situations like thunderstorms, travel, or separation anxiety.

Antioxidant Supplements:

Description: These supplements contain antioxidants like vitamins C and E, selenium, and coenzyme Q10, which help neutralize free radicals in the body.

Benefits: Supports immune health, reduces oxidative stress, and may help in preventing chronic diseases such as cancer.

Digestive Enzymes:

Description: Digestive enzyme supplements help break down food more effectively, aiding in the digestion of proteins, fats, and carbohydrates.

Benefits: Supports digestive health, particularly in pets with pancreatic insufficiency or other digestive disorders.

Skin and Coat Supplements:

Description: These supplements often contain ingredients like biotin, omega-3 fatty acids, and zinc to promote healthy skin and a shiny coat.

Benefits: Helps reduce shedding, dandruff, and dry skin, contributing to a healthier appearance.

Immune System Support:

Description: Immune-boosting supplements may include ingredients like colostrum, beta-glucans, and echinacea, which are known to support the immune system.

Benefits: Enhances the pet's natural defenses against illness, particularly useful for pets recovering from illness or surgery.

Dental Supplements:

Description: Dental supplements include products like oral sprays, water additives, and chewables designed to support dental health.

Benefits: Helps reduce plaque and tartar buildup, freshens breath, and supports overall oral hygiene.

Key Player Analysis

Virbac

Pet Honesty

Nutramax Laboratories, Inc.

Mars, Incorporated

FoodScience Corporation

Zoetis, Inc.

Zesty Paws

Ark Naturals

NOW Foods

More About Report- https://www.credenceresearch.com/report/pet-food-and-supplement-market

The future outlook for the pet food and supplement market is highly promising, driven by several key trends and factors that are expected to shape the industry over the coming years. As pet ownership continues to rise globally, particularly in emerging markets, the demand for high-quality, nutritious, and tailored pet food and supplements is set to increase. Here’s a detailed look at the future outlook:

1. Continued Growth in Premium and Specialty Products

Humanization of Pets: The ongoing trend of pet humanization, where pets are increasingly viewed as family members, will continue to drive demand for premium and specialty pet food products. This includes organic, grain-free, and natural pet foods, as well as customized diets tailored to specific health needs or preferences. As pet owners seek to provide the best for their pets, the market for premium pet food is expected to grow significantly.

Personalized Nutrition: Advances in technology and nutrition science are enabling the development of personalized pet diets, based on factors such as age, breed, activity level, and even genetic makeup. The trend towards personalized nutrition, which is already gaining traction in the human food market, is likely to become a key growth area in pet food as well.

2. Expansion of the Pet Supplement Market

Health and Wellness Focus: Just as in human health, there is a growing focus on preventive care and wellness in pet health. This is driving the demand for pet supplements that support joint health, digestive health, skin and coat health, and overall immune function. The aging pet population, particularly in developed markets, will also contribute to the increasing use of supplements to manage age-related conditions.

Growth in Functional Supplements: The market for functional supplements, such as probiotics, omega-3 fatty acids, and CBD, is expected to expand as more pet owners seek natural and holistic solutions for their pets’ health issues. These products offer targeted benefits and are becoming an integral part of many pets’ daily routines.

3. Rise of Sustainable and Ethical Products

Environmental and Ethical Considerations: Sustainability and ethical sourcing are becoming increasingly important to pet owners. The demand for sustainably sourced ingredients, eco-friendly packaging, and transparency in supply chains will shape the future of the pet food and supplement market. Brands that prioritize sustainability and ethical practices are likely to attract a growing segment of eco-conscious consumers.

Alternative Proteins: The environmental impact of traditional meat production is leading to the exploration of alternative protein sources in pet food, such as plant-based proteins, insect-based proteins, and lab-grown meat. These alternatives not only address sustainability concerns but also appeal to pet owners looking for novel, nutritious options for their pets.

4. Technological Advancements and Innovation

Smart Feeding Solutions: Technology is playing an increasingly important role in pet care, with the development of smart feeders, automated dispensers, and mobile apps that track pets’ eating habits and health metrics. These innovations offer convenience and peace of mind to pet owners, while also providing data that can be used to refine and optimize pet diets.

Advanced Manufacturing and Quality Control: Innovations in food processing and quality control technologies will continue to improve the safety, nutritional value, and palatability of pet food and supplements. Enhanced traceability systems will also ensure that products meet the highest standards of safety and quality.

5. Growth in E-commerce and Direct-to-Consumer Models

Online Shopping Trends: The shift towards e-commerce, accelerated by the COVID-19 pandemic, is expected to continue shaping the pet food and supplement market. Online platforms provide consumers with a wide range of products, including niche and premium brands that may not be available in traditional retail stores. The convenience of home delivery, along with subscription services for regular supplies of pet food and supplements, will drive continued growth in online sales.

Direct-to-Consumer (DTC) Brands: DTC brands that offer customized, subscription-based pet food and supplements are gaining popularity. These brands often use data-driven approaches to personalize offerings and build direct relationships with consumers, allowing for better customer engagement and loyalty.

6. Expansion into Emerging Markets

Rising Pet Ownership: Emerging markets, particularly in Asia-Pacific and Latin America, are witnessing an increase in pet ownership due to rising disposable incomes, urbanization, and changing cultural attitudes towards pets. As a result, these regions are becoming important growth markets for pet food and supplements, with significant opportunities for both local and international brands.

Localization of Products: As brands expand into emerging markets, there will be a focus on localizing products to meet regional preferences and dietary needs. This includes formulating pet foods that cater to local tastes, dietary traditions, and nutritional requirements, as well as adapting marketing strategies to resonate with local consumers.

7. Increased Focus on Pet Health and Longevity

Preventive Healthcare: As pet owners become more aware of the impact of nutrition on their pets’ long-term health, there will be a growing emphasis on preventive healthcare through diet and supplements. Products that support longevity, enhance quality of life, and manage chronic conditions will be in high demand.

Veterinary Collaboration: The collaboration between pet food companies and veterinary professionals will likely strengthen, leading to the development of more scientifically backed, veterinary-recommended products. This collaboration will also help in educating pet owners about the benefits of tailored nutrition and supplements for their pets.

8. Challenges and Opportunities in Regulation

Regulatory Compliance: As the market for pet food and supplements grows, regulatory scrutiny is expected to increase, particularly concerning the safety, labeling, and marketing of products. Companies that proactively address these regulatory requirements, ensuring compliance and transparency, will build trust with consumers and gain a competitive edge.

Innovation within Regulation: The evolving regulatory landscape will also drive innovation as companies develop new products and formulations that meet or exceed regulatory standards. This includes the potential for new categories of supplements or fortified foods that address emerging health concerns in pets.

Segments:

Based on Pet:

Dog

Cat

Freshwater Fish

Others

Based on Application:

Multivitamins

Skin and Coat

Hip and Joint

Prebiotics and Probiotics

Calming

Others

Based on Source:

Organic

Conventional

Based on Distribution Channel:

Offline

Online

Browse the full report –  https://www.credenceresearch.com/report/pet-food-and-supplement-market

Browse Our Blog: https://www.linkedin.com/pulse/pet-food-supplement-market-analysis-global-industry-trends-beeqf

Contact Us:

Phone: +91 6232 49 3207

Email: sales@credenceresearch.com

Website: https://www.credenceresearch.com

[credenceresearchdotblog]

The animal drug compounding market is experiencing remarkable growth, with projections indicating a substantial increase from USD 2,315.23 million in 2023 to an estimated USD 5,025.23 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.66%.The animal drug compounding market is a critical yet often overlooked segment within the broader veterinary pharmaceutical industry. Compounding refers to the process of creating customized medications by combining, mixing, or altering ingredients to meet the specific needs of an individual animal. This practice is essential when commercially available drugs are not suitable due to dosage requirements, allergies, or other unique needs of a patient. As pet ownership continues to rise globally and veterinary care advances, the demand for compounded animal drugs is increasing, driving growth in this specialized market.

Browse the full report at https://www.credenceresearch.com/report/animal-drug-compounding-market

Market Overview and Growth Drivers

The global animal drug compounding market has witnessed significant growth in recent years, and this trend is expected to continue. Several factors contribute to this expansion, including the increasing pet population, heightened awareness about animal health, and the growing demand for personalized veterinary care. Additionally, the rise in chronic diseases among pets, such as arthritis, cancer, and diabetes, necessitates the use of compounded medications tailored to the specific health conditions of individual animals.

One of the key drivers of this market is the limitation of commercially available veterinary medications. Often, these drugs do not come in appropriate dosages or forms for specific animals, leading veterinarians to rely on compounding pharmacies. For instance, a large dog may require a higher dosage of a medication than what is available in standard formulations, or a cat may need a drug in a flavored form to ensure compliance. Compounding allows for such customization, enhancing the efficacy and safety of treatments.

Regulatory Landscape and Challenges

The regulatory environment for animal drug compounding varies significantly across regions, which presents both opportunities and challenges. In the United States, the Food and Drug Administration (FDA) regulates compounded animal drugs under the Animal Medicinal Drug Use Clarification Act (AMDUCA). While compounding is allowed, it must be done under strict conditions, primarily when no FDA-approved drug is available in the required form or dosage.

However, the lack of standardized regulations globally poses a challenge for market players. In some regions, the absence of clear guidelines leads to variability in the quality of compounded medications, which can affect both efficacy and safety. Moreover, compounded drugs do not undergo the same rigorous testing as FDA-approved medications, leading to concerns about their consistency and reliability. This regulatory ambiguity can limit market growth, as veterinary professionals and pet owners may hesitate to use compounded medications due to safety concerns.

Market Segmentation and Key Players

The animal drug compounding market can be segmented by product type, application, end-user, and region. By product type, the market includes anti-infective, anti-inflammatory, and other drugs, such as those used for pain management and behavioral disorders. The application segment is divided into companion animals, such as dogs, cats, and horses, and livestock, including cattle, poultry, and swine.

Companion animals represent the largest segment of the market due to the rising trend of pet humanization, where pets are increasingly considered part of the family, leading to greater willingness among owners to invest in their healthcare. Within this segment, dogs and cats are the primary recipients of compounded medications, driven by their prevalence as pets and the variety of health issues they face.

Future Prospects and Market Trends

The future of the animal drug compounding market looks promising, with several trends likely to shape its trajectory. The increasing adoption of telemedicine in veterinary care is expected to boost demand for compounded medications, as remote consultations often require the delivery of customized treatments. Additionally, advancements in pharmaceutical technology, such as the development of more precise compounding techniques and the use of better flavoring agents, are likely to enhance the appeal of compounded drugs.

Moreover, as regulatory bodies continue to refine their guidelines, the market could see improved standardization and quality assurance, making compounded drugs more reliable and widely accepted. This, coupled with the growing focus on animal welfare and the rising prevalence of chronic diseases in pets, is expected to sustain the market's growth in the coming years.

Key player:

WEDGEWOOD PHARMACY

Vimian

Custom Med Compounding Pharmacy

Central Compounding Center South.

Akina Animal Health

Wellness Pharmacy of Cary.

Miller’s Pharmacy

Triangle Compounding.

Davis Islands Pharmacy and Compounding Lab

Segmentation:

By Animal Type

Companion Animals

Dogs

Cats

Others

Livestock Animals

By Product

Anti-infective Agents

Anti-inflammatory Agents

Hormones & Substitutes

CNS Agents

Others

By Route of Administration

Oral

Injectable

Topical

Others

By Dosage Form

Suspensions

Solutions

Capsules

By Regional

North America

US.

Canada

Europe

UK.

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

Japan

China

India

South Korea

Australia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

South Africa

Saudi Arabia

Rest of Middle East & Africa

Browse the full report at https://www.credenceresearch.com/report/animal-drug-compounding-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[tamanna31]

Veterinary Orthopedic Medicines Market Poised for Steady Growth in the Future

Veterinary Orthopedic Medicines Industry Overview

The global veterinary orthopedic medicines market size was estimated at USD 1.62 billion in 2023 and is expected to grow at a CAGR of 8.6% from 2024 to 2030.

The growth can be attributed to rising prevalence of orthopedic disorders in animals, the growing uptake of pet insurance, an increase in the aging animal population, and advancements in veterinary orthopedic medicines. Orthopedic issues can negatively impact an animal's quality of life by affecting the bones, muscles, and joints. Canine dysplasia of the elbow & hips and arthritis are among common conditions. Several factors contribute to orthopedic problems in animals, including aging, poor diet, and obesity. Recent studies have shown a rise in obesity among animals such as dogs and horses. For instance, an NCBI study in 2023 on horses revealed a 45% obesity rate.

Gather more insights about the market drivers, restrains and growth of the Veterinary Orthopedic Medicines Market

Stem cell therapy has recently gained popularity and generated significant interest in research & clinical settings. In veterinary medicine, stem cell therapy has been studied as a potential treatment option for various health complications such as dermatological, orthopedic, dental, etc. The use of stem cells in these diseases is still in its infancy, but the potential for stem cell therapy in veterinary medicine is extensive. For instance, StemcellX, a UK-based company, currently has two stem-cell products in the pipeline for application in dogs and horses. The veterinary orthopedic medicines market is growing due to increase in prevalence of Osteoarthritis (OA) and other Degenerative Joint Diseases (DJD) among various animals like dogs, cats, & horses, among others. According to estimates from a 2022 study in Frontiers of Veterinary Sciences, OA is the most common musculoskeletal disorder in dogs, and about 1 in 4 dogs suffer from it. Another research study from the Veterinary Ireland Journal stated that approximately 40% of all cats suffer from OA. Estimates provided by the American Animal Hospital Association (AAHA) reveal that 40% to 92% of cats experience joint pain due to OA or other DJD. Furthermore, the studies suggest possible underdiagnosis of these conditions in these animals. Figures provided by Zoetis indicate that out of the total diagnosed cases of canine OA in the US, only 33% are treated.

Furthermore, University of Illinois data suggests that athletic horses are at a high risk of developing OA that causes lameness. It is estimated that over 50% of horses older than 15 years suffer from OA, and in horses over 30 years of age, this number increases to more than 80% to 90%. OA affects the performance and wellbeing of athletic horses. For early diagnosis, it is important to understand causal & developmental pathways and prescribe the right treatment. Moreover, several pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article in USA Today, 26% of surveyed Americans stated they spend between USD 51 & USD 100 a month on their dogs. The same number of people (26%) spend from USD 101 to USD 250 monthly on dog care. Ownership of a dog can cost up to USD 5,000 in some cases. About 66% of the respondents said they had to cut down on their personal expenses to meet the rising costs of owning a pet. Others have taken out loans or asked for financial assistance to pay for the care of animals.

Browse through Grand View Research's Animal Health Industry Research Reports.

The global livestock monitoring market size was estimated at USD 4.01 billion in 2023 and is anticipated to grow at a CAGR of 11.56% from 2024 to 2030. 

The North America and Europe exotic companion animal market size was estimated at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030.

Key Veterinary Orthopedic Medicines Company Insights

Some of the key players operating in the market are Zoetis Inc; Boehringer Ingelheim; Elanco Animal Health, Inc.; and Merck Animal Health (Merck & Co. Inc). Industry leaders like Zoetis, Inc.; Boehringer Ingelheim; Elanco Animal Health; American Regent, Inc.; Merck Animal Health (Merck & Co. Inc); and Vetoquinol S.A. are investing significantly in the R&D of novel medicines for musculoskeletal complications prevalent in various animals. Companies like Ardent Animal Health, LLC; VetStem, Inc.; and MEDREGO LLC are focusing on developing specialized biologics like stem cells, PRP, and other biologics to effectively combat orthopedic conditions in animals.

Zoetis is one of the leading veterinary product companies in the world. It discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, & other technologies for the treatment of various diseases in companion animals, as well as livestock animals. It has a widespread network in over 45 countries.

Elanco Animal Health has operated in the veterinary industry for over 65 years. It is a subsidiary of the pharmaceutical products giant Elli Lilly & Company. The company is among the top four global veterinary product manufacturers, with over 200 brands and a presence in over 90 countries.

Hyalogic, Bioiberica S.A.U, and Contipro A.S. are some of the emerging market participants in the veterinary orthopedic medicines market.

Hyalogic is a company that specializes in and focuses on manufacturing products made from high-molecular-weight hyaluronic acid, which has hydrating and lubricating properties. Its product portfolio includes skin care, personal care, joint care, etc., for humans and specialized joint care products for animals.

Key Veterinary Orthopedic Medicines Companies:

The following are the leading companies in the veterinary orthopedic medicines market. These companies collectively hold the largest market share and dictate industry trends.

Zoetis Inc.

Boehringer Ingelheim

Elanco Animal Health

American Regent, Inc.

Merck Animal Health (Merck & Co. Inc)

Vetoquinol S.A.

Ceva Sante Animale

Virbac

Biogenesis Bago

Ardent Animal Health, LLC

Bioiberica S.A.U

PetVivo Holdings, Inc. (Spryng)

Contipro A.S.

VetStem, Inc.

Enso Discoveries

Contura Vet US

T-Cyte Therepeutics

MEDREGO LLC

Bimeda U.S.

Hyalogic

Hester Biosciences .

Order a free sample PDF of the Veterinary Orthopedic Medicines Market Study, published by Grand View Research.

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

[mitalipingale]

https://rollbol.com/blogs/1811907/Veterinary-Pain-Management-Market-Analysis-Size-Share-and-Forecast-2031

The Veterinary Pain Management Market in 2023 is US$ 1.92 billion, and is expected to reach US$ 3.29 billion by 2031 at a CAGR of 6.9%.

[ashu-digiroads-01]

Nourishing Joint Health: Exploring Dehydrated Dog Food for Dogs with Joint Issues

Introduction:

As pet owners, we strive to provide the best care for our furry companions, especially when they face health challenges like joint issues. When it comes to addressing these concerns, nutrition plays a vital role. In recent years, the pet food industry has witnessed a significant shift towards healthier and more specialized options, such as dehydrated dog food market. This trend has been particularly beneficial for dogs with joint problems, offering them a balanced diet while also addressing their specific needs. In this blog, we delve into the benefits of dehydrated dog food for dogs with joint issues and explore its growing market.

Understanding Joint Issues in Dogs:

Joint issues, including arthritis, hip dysplasia, and other degenerative conditions, are common among dogs, especially as they age. These conditions can cause pain, stiffness, and reduced mobility, significantly impacting the quality of life of our beloved pets. While veterinary care and medication are essential components of managing joint problems, dietary interventions can also play a crucial role in supporting joint health.

The Role of Nutrition:

Proper nutrition is essential for maintaining overall health and well-being in dogs, including those with joint issues. Certain nutrients, such as glucosamine, chondroitin, omega-3 fatty acids, and antioxidants, have been found to promote joint health and alleviate symptoms associated with joint conditions. Additionally, maintaining a healthy weight is crucial for reducing strain on the joints and minimizing discomfort.

Dehydrated Dog Food: A Nutrient-Rich Option:

Dehydrated dog food has gained popularity in recent years due to its numerous health benefits. Unlike traditional kibble, which undergoes high-heat processing that may degrade some nutrients, dehydrated dog food market is made by gently removing moisture from fresh ingredients without exposing them to extreme temperatures. This process helps preserve the natural nutrients and flavors, making it a highly nutritious option for dogs with joint issues.

Benefits of Dehydrated Dog Food for Joint Health:

Nutrient Retention: Dehydrated dog food retains more nutrients compared to traditional kibble, ensuring that dogs receive essential vitamins, minerals, and joint-supporting compounds.

High-Quality Ingredients: Many dehydrated dog food brands use high-quality, whole food ingredients, including lean proteins, fruits, vegetables, and grains, which contribute to overall health and joint function.

Digestibility: The dehydration process breaks down ingredients, making them easier to digest and absorb, which is beneficial for dogs with sensitive stomachs or digestive issues often associated with joint problems.

Customizable Formulas: Some dehydrated dog food brands offer customizable formulas tailored to specific health needs, including joint support. These formulations may contain elevated levels of glucosamine, chondroitin, and other joint-friendly ingredients.

Weight Management: Dehydrated dog food can help maintain a healthy weight, reducing the risk of obesity and alleviating strain on the joints.

The Dehydrated Dog Food Market:

The demand for dehydrated dog food has been steadily rising as pet owners seek healthier alternatives for their furry companions. The market offers a wide range of options, including various flavors, formulations, and dietary profiles to accommodate different breeds, sizes, and health concerns. With an increasing focus on pet health and wellness, the dehydrated dog food market is expected to continue its growth trajectory in the coming years.

Conclusion:

Dehydrated dog food presents a promising solution for pet owners seeking to support their dogs' joint health and overall well-being. By providing a nutrient-rich diet that is easy to digest and tailored to specific health needs, dehydrated dog food offers a holistic approach to managing joint issues in dogs. As the market continues to expand and innovate, pet owners have access to an array of options to nourish their furry friends and ensure they live happy, active lives, free from joint discomfort.